Captrust Financial Advisors Genmab A/S Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Genmab A/S stock. As of the latest transaction made, Captrust Financial Advisors holds 32,823 shares of GMAB stock, worth $677,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,823

Previous 44,850 26.82%

Holding current value

$677,794

Previous $1.13 Million 29.02%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $286,723 - $342,528	-12,027 Reduced 26.82%	32,823 $800,000
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $36,513 - $43,982	-1,453 Reduced 3.14%	44,850 $1.13 Million
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $184,032 - $228,177	6,963 Added 17.7%	46,303 $1.38 Million
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $140,398 - $178,086	-5,025 Reduced 11.33%	39,340 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $1.37 Million - $1.64 Million	38,797 Added 696.79%	44,365 $1.56 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $19,448 - $22,328	-520 Reduced 8.54%	5,568 $211,000
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $45,448 - $56,315	-1,303 Reduced 17.63%	6,088 $229,000
Q4 2022 Feb 15, 2023	BUY	$33.8 - $47.06 $249,815 - $347,820	7,391 New	7,391 $313,000
Q2 2022 Aug 23, 2022	SELL	$26.83 - $38.57 $38,903 - $55,926	-1,450 Reduced 37.26%	2,442 $79,000
Q2 2022 Aug 16, 2022	BUY	$26.83 - $38.57 $33,108 - $47,595	1,234 Added 46.43%	3,892 $126,000
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $31,476 - $40,354	1,017 Added 61.97%	2,658 $96,000
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $8,142 - $10,696	227 Added 16.05%	1,641 $65,000
Q3 2021 Nov 16, 2021	BUY	$41.55 - $48.72 $11,052 - $12,959	266 Added 23.17%	1,414 $62,000
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $2,959 - $4,011	90 Added 8.51%	1,148 $47,000
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $20,345 - $29,215	658 Added 164.5%	1,058 $35,000
Q3 2020 Nov 17, 2020	BUY	$33.07 - $38.68 $13,228 - $15,472	400 New	400 $15,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Genmab A/S Transaction History